title: Use of adalimumab in treatment of autoimmune sensorineural hearing loss: a word of caution.
authors.forename: Richard
authors.initials: R
authors.lastname: Conway
authors.forename: Suleman
authors.initials: S
authors.lastname: Khan
authors.forename: Darragh
authors.initials: D
authors.lastname: Foley-Nolan
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000150:complications*; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab